Manna Research   Report issue

For profit Phase 2 Phase 3
Founded: Toronto ON Canada (2005)
Status: Acquired by LMC Diabetes & Endocrinology Ltd. (2015)

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

trigonellamide (1 trial)

Drugs in Phase 2 Trials (1)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertriglyceridemia (Phase 3)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2